These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32197097)

  • 1. Disease X: accelerating the development of medical countermeasures for the next pandemic.
    Simpson S; Kaufmann MC; Glozman V; Chakrabarti A
    Lancet Infect Dis; 2020 May; 20(5):e108-e115. PubMed ID: 32197097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using
    Zayed H
    Front Immunol; 2020; 11():2051. PubMed ID: 32922408
    [No Abstract]   [Full Text] [Related]  

  • 3. A Veterinary Vaccine Development Process Map to assist in the development of new vaccines.
    Francis MJ
    Vaccine; 2020 Jun; 38(29):4512-4515. PubMed ID: 32418794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine development and the way forward.
    Arora NK; Das MK
    Indian J Public Health; 2020 Jun; 64(Supplement):S108-S111. PubMed ID: 32496238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Vaccine: Light at the End of the Tunnel.
    Ella KM; Mohan VK
    Indian Pediatr; 2020 May; 57(5):407-410. PubMed ID: 32291382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first cohort of the COVID-19 patients in Vietnam and the national response to the pandemic.
    Nguyen NH; Van Nguyen T; Nguyen AQ; Van Nguyen P; Nguyen TNM
    Int J Med Sci; 2020; 17(16):2449-2453. PubMed ID: 33029087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of COVID-19 vaccine development.
    Taxt AM; Grødeland G; Lind A; Müller F
    Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19 pandemic: global epidemiological trends and China's subsequent preparedness and responses].
    Guo Y; Huang YM; Huang J; Jin YZ; Jiang W; Liu PL; Liu FJ; Ma JX; Ma JY; Wang Y; Xie Z; Yin H; Zhao CS; Zhou SD; Zhang J; Zheng ZJ;
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 May; 41(5):642-647. PubMed ID: 32164401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [World Health Organization's response mechanisms for COVID-19].
    Jing WZ; Liu M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1385-1389. PubMed ID: 33076589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 12. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronavirus outbreak: the role of companies in preparedness and responses.
    Fadel M; Salomon J; Descatha A
    Lancet Public Health; 2020 Apr; 5(4):e193. PubMed ID: 32119831
    [No Abstract]   [Full Text] [Related]  

  • 14. A timely update of global COVID-19 vaccine development.
    Klavinskis LS; Liu MA; Lu S
    Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The narrow road to a COVID-19 vaccine.
    Maurya SP; Das N; Gautam H; Singh R; Das BK
    Indian J Pharmacol; 2020; 52(4):333-334. PubMed ID: 33078736
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of a quarantine strategy is an important path to a normalized response to COVID-19.
    Zhu H; Lu H
    Biosci Trends; 2020 Nov; 14(5):396-398. PubMed ID: 33100292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.
    Mellors J; Tipton T; Longet S; Carroll M
    Front Immunol; 2020; 11():1450. PubMed ID: 32733480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unwavering Regulatory Safeguards for COVID-19 Vaccines.
    Shah A; Marks PW; Hahn SM
    JAMA; 2020 Sep; 324(10):931-932. PubMed ID: 32766736
    [No Abstract]   [Full Text] [Related]  

  • 19. [Expanding the pandemic influenza preparedness framework to the epidemic of COVID-19].
    Li BZ; Li MS; Huang JY; Chen YY; Lu YH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):597-601. PubMed ID: 32842276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
    Johnson RA; White RC; Disbrow GL
    Hum Vaccin Immunother; 2022 Nov; 18(6):2129930. PubMed ID: 36302122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.